These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12486589)

  • 1. [Nociceptin and the ORL1 receptor: pharmacology of a new opioid receptor].
    Grond S; Meuser T; Pietruck C; Sablotzki A
    Anaesthesist; 2002 Dec; 51(12):996-1005. PubMed ID: 12486589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nociceptin/orphanin FQ: role in nociceptive information processing.
    Yamamoto T; Nozaki-Taguchi N; Sakashita Y; Kimura S
    Prog Neurobiol; 1999 Apr; 57(5):527-35. PubMed ID: 10215100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.
    Meunier JC
    Eur J Pharmacol; 1997 Dec; 340(1):1-15. PubMed ID: 9527501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors.
    Fawzi AB; Zhang H; Weig B; Hawes B; Graziano MP
    Eur J Pharmacol; 1997 Oct; 336(2-3):233-42. PubMed ID: 9384238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ORL
    Wu Q; Liu L
    J Mol Neurosci; 2018 Sep; 66(1):10-16. PubMed ID: 30074175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
    Mandyam CD; Thakker DR; Christensen JL; Standifer KM
    J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.
    Narita M; Mizoguchi H; Oji DE; Dun NJ; Hwang BH; Nagase H; Tseng LF
    Br J Pharmacol; 1999 Nov; 128(6):1300-6. PubMed ID: 10578145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids.
    Mollereau C; Moisand C; Butour JL; Parmentier M; Meunier JC
    FEBS Lett; 1996 Oct; 395(1):17-21. PubMed ID: 8849681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
    Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis toxin-insensitive signaling of the ORL1 receptor: coupling to Gz and G16 proteins.
    Chan JS; Yung LY; Lee JW; Wu YL; Pei G; Wong YH
    J Neurochem; 1998 Nov; 71(5):2203-10. PubMed ID: 9798948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid activity profiles indicate similarities between the nociceptin/orphanin FQ and opioid receptors.
    Hawkinson JE; Acosta-Burruel M; Espitia SA
    Eur J Pharmacol; 2000 Feb; 389(2-3):107-14. PubMed ID: 10688973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide.
    Shimohigashi Y; Hatano R; Fujita T; Nakashima R; Nose T; Sujaku T; Saigo A; Shinjo K; Nagahisa A
    J Biol Chem; 1996 Sep; 271(39):23642-5. PubMed ID: 8798582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two C-terminal amino acids, Ser(334) and Ser(335), are required for homologous desensitization and agonist-induced phosphorylation of opioid receptor-like 1 receptors.
    Wang HL; Kuo YL; Hsu CY; Huang PC; Li AH; Chou AH; Yeh TH; Chen YL
    Cell Signal; 2006 May; 18(5):670-8. PubMed ID: 16019191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cloning of prepronociceptin has led to the discovery of other biologically active peptides].
    Costentin J; Florin S; Suaudeau C; Meunier JC
    C R Seances Soc Biol Fil; 1998; 192(6):1099-109. PubMed ID: 10101606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of CCL2/MCP-1 and CCL5/RANTES expression by nociceptin in human monocytes.
    Kaminsky DE; Rogers TJ
    J Neuroimmune Pharmacol; 2008 Jun; 3(2):75-82. PubMed ID: 18247127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A.
    Mollereau C; Mouledous L; Lapalu S; Cambois G; Moisand C; Butour JL; Meunier JC
    Mol Pharmacol; 1999 Feb; 55(2):324-31. PubMed ID: 9927625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
    Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
    Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermal nociceptin elicits itch-associated responses through leukotriene B(4) in mice.
    Andoh T; Yageta Y; Takeshima H; Kuraishi Y
    J Invest Dermatol; 2004 Jul; 123(1):196-201. PubMed ID: 15191560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bi-directional modulation of 5-hydroxytryptamine-induced plasma extravasation in the rat knee joint by nociceptin.
    Grond S; Gabriel A; Pietruck C; Yu LC; Xie GX; Pierce Palmer P
    Neuroscience; 2001; 103(4):1085-92. PubMed ID: 11301215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors.
    Schlicker E; Werthwein S; Kathmann M; Bauer U
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):418-22. PubMed ID: 9826063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.